(Q46383982)

21 December 2017

title

Depsipeptide (FR901228) enhances the cytotoxic activity of TRAIL by redistributing TRAIL receptor to membrane lipid rafts (English)

1 reference

21 December 2017

0 references

1 reference

Rebecca L Vanoosten

1

1 reference

21 December 2017

Jill M Moore

series ordinal

2

1 reference

21 December 2017

Aaron T Ludwig

series ordinal

3

1 reference

21 December 2017

Thomas S Griffith

series ordinal

4

1 reference

21 December 2017

publication date

1 April 2005

1 reference

21 December 2017

published in

Molecular Therapy

1 reference

21 December 2017

volume

11

1 reference

21 December 2017

page(s)

542-552

1 reference

21 December 2017

issue

4

1 reference

21 December 2017

Gene therapy progress and prospects: adenoviral vectors

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Systemic delivery of insulin via an enhancer-free ocular device

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Local delivery of chemotherapy: a supplement to existing cancer treatments. A case for surgical pastes and coated stents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Viral vector delivery in solid-state vehicles: gene expression in a murine prostate cancer model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Histone deacetylases, transcriptional control, and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Histone deacetylases and cancer: causes and therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Histone deacetylase inhibitors as new cancer drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. III. Antitumor activities on experimental tumors in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Histone deacetylase inhibitor FK228 inhibits tumor angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

A phase I trial of depsipeptide (FR901228) in patients with advanced cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

A novel combination of suicide gene therapy and histone deacetylase inhibitor for treatment of malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Amplification of transgene expression in vitro and in vivo using a novel inhibitor of histone deacetylase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Suppression of tumor growth following intralesional therapy with TRAIL recombinant adenovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Identification and characterization of a new member of the TNF family that induces apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

The topoisomerase I inhibitor topotecan increases the sensitivity of prostate tumor cells to TRAIL/Apo-2L-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

The histone deacetylase inhibitor suberic bishydroxamate: a potential sensitizer of melanoma to TNF-related apoptosis-inducing ligand (TRAIL) induced apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Sensitization of mesothelioma to TRAIL apoptosis by inhibition of histone deacetylase: role of Bcl-xL down-regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Interleukin 1 beta-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

CD95 Signaling via Ceramide-rich Membrane Rafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

An essential role for membrane rafts in the initiation of Fas/CD95-triggered cell death in mouse thymocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Location is everything: lipid rafts and immune cell signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Adenoviruses in oncology: a viable option?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Adenovirus-mediated interferon-beta gene therapy suppresses growth and metastasis of human prostate cancer in nude mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Induction of cell cycle arrest and apoptosis in human prostate carcinoma cells by a recombinant adenovirus expressing p27(Kip1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

7 January 2021

Gene therapy for cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Acetylation of general transcription factors by histone acetyltransferases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Regulation of activity of the transcription factor GATA-1 by acetylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Effects of FK228, a novel histone deacetylase inhibitor, on human lymphoma U-937 cells in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Apoptosis: a link between cancer genetics and chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Acceleration of human neutrophil apoptosis by TRAIL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

TRAIL/Apo-2 ligand induces primary plasma cell apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

The apoptotic ligands TRAIL, TWEAK, and Fas ligand mediate monocyte death induced by autologous lupus T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Tumor necrosis factor-related apoptosis-inducing ligand induces neuronal death in a murine model of HIV central nervous system infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

CD40 signaling in human dendritic cells is initiated within membrane rafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Restricted localization of the TNF receptor CD120a to lipid rafts: a novel role for the death domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

A simple method for the rapid generation of recombinant adenovirus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Comparison of in vitro cell cytotoxic assays for tumor necrosis factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

10.1016/J.YMTHE.2004.12.008

7 January 2021

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

15771957

1 reference

21 December 2017